A written informed consent was obtained from the patient. Coronary artery bypass grafting and EVAR were performed. The patient underwent 4 vessels CABG with the aid of cardiopulmonary bypass (CPB) under aortic cross-clamp, where myocardial protection was achieved using antegrade cardioplegia and mild systemic hypotermia (32°C). The left internal thoracic artery was anastomosed to the LAD1, saphenous venous grafts were anastomosed to LAD2, Cx, and RCAPD. Duration of CPB was 62 min and aortic cross-clamp time was 36 min. The CABG was uneventful and we stepped up to EVAR, when we reached the stage of heparin neutralization with protamine administration after decannulation and before chest closure. Heparin was 3/4 neutralized by protamine as to keep activated clotting time between 180 and 200 sec and EVAR was performed through bilateral femoral incisions which was planned and marked according to Doppler ultrasonography (GE Loqic S8, Ref: 5669845, GE Ultrasound Korea, Ltd., Gyeonggi-do, Korea)-guided preoperative bedside femoral arterial mapping. Common femoral arteries (CFA) were surgically reached and prepared. A modular-type endograft (Medtronic Inc., Minneapolis, MN, USA) was implanted with trunkipsilateral component from the right CFA and the attachment of contralateral component from the left CFA. Control double subtracted angiography was performed, and the flow through stent graft was found to be normal without any endoleak. The chest drains were placed and sternal and femoral incisions were closed respectively. The patient was transferred to the postoperative cardiovascular surgery intensive care unit.
Duration of total hybrid procedure was 254 min. Extubation duration was six hour. The patient was transferred to his room at postoperative 22 hours and discharged on postoperative Day 7 after an uneventful postoperative follow-up period.
It is a well-known fact that AAA ruptures may complicate the postoperative follow-up of CABG, where MI may result in morbidity and mortality in patients undergoing surgery or endovascular procedure for AAAs.[3,4] To avoid undesired disastrous scenarios arising from concomitant aortic or cardiac pathologies of p atients u ndergoing CABG or EVAR, hybrid synchronous CABG and EVAR may be useful. The series reported emphasizes the acceptable morbidity and mortality rates of hybrid synchronous procedures, compared to staged procedures. Postoperative recovery times in hybrid synchronous procedures are as similar as in staged procedures.[5,6]
It is recommended to perform EVAR first to avoid from possible hemodynamic problems which may occur after CPB. Coronary artery bypass grafting is also advised on beating heart or with the assistance of CPB, but without cross-clamping. However, it is also emphasized that each procedure should specifically be tailored according to the pathology and needs of the patient who is planned to undergo hybrid procedure.[5,6]
The most possible postoperative complication is acute renal failure, due to the additive effects of CPB and contrast agents used during EVAR. However, a team that is highly experienced in EVAR and CABG and the hybrid operating room designed for complex endovascular procedures may be the key for reducing postoperative complications and have an important role in yielding favorable outcomes.[5,6]
In conclusion, we believe that the future will be the era of hybrid procedures which combines traditional, minimally invasive, or robotic surgery with endovascular procedures. Therefore, we advocate that, with the help of improving technology and innovations, experienced teams consist of radiologists, cardiologists, anesthesiologists, and cardiovascular surgeons would play a key role in this era of cardiovascular hybrid procedures.
Declaration of conflicting interests
The authors declared no conflicts of interest with respect to
the authorship and/or publication of this article.
Funding
The authors received no financial support for the research
and/or authorship of this article.
1) Golden MA, Whittemore AD, Donaldson MC, Mannick JA.
Selective evaluation and management of coronary artery
disease in patients undergoing repair of abdominal aortic
aneurysms. A 16-year experience. Ann Surg 1990;212:415-20.
2) Gangemi JJ, Kron IL, Ross SD, Tribble CG, Kern JA. The
safety of combined cardiac and vascular operations: how
much is too much? Cardiovasc Surg 2000;8:452-6.
3) Sun T, Cheng YT, Zhang HJ, Chen SH, Zhang DH, Huang
J, et al. Severe coronary artery disease in Chinese patients
with abdominal aortic aneurysm: prevalence and impact on
operative mortality. Chin Med J (Engl) 2012;125:1030-4.
4) Blackbourne LH, Tribble CG, Langenburg SE, Mauney
MC, Buchanan SA, Sinclair KN, et al. Optimal timing of
abdominal aortic aneurysm repair after coronary artery
revascularization. Ann Surg 1994;219:693-6.